The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia
Condition: Barrett's Oesophagus Interventions: Diagnostic Test: Cytosponge test; Diagnostic Test: Assessment of the panel of molecular biomarkers: IM-SCORE, TFF3 protein expression, methylation panel, p53 mutation; Diagnostic Test: Oesophagogastroduodenoscopy Sponsors: University of Cambridge; University of Nottingham Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2019 Category: Research Source Type: clinical trials